Código QR (código de barras bidimensional)

Baseline vitamin D status is associated with glycemic and weight loss outcomes in patients with type 2 diabetes treated with semaglutide

ObjectiveSemaglutide, a glucagon-like peptide-1 receptor agonist, is an established therapy for type 2 diabetes (T2D), offering robust glycemic control and weight reduction. Vitamin D has been implicated in metabolic regulation, yet its influence on semaglutide-induced outcomes remains unclear.Resea...

ver descrição completa

Na minha lista:
Principais autores: Ariel Israel, Mahmud Moed, Hala Abo Fanne, Aviv Kedem, Mahmoud Odeh, Kareem Abu Rashed, Tayser Marzook, Isis Abumouch, Rami Abu Fanne
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2026-04-01
coleção:Frontiers in Nutrition
Assuntos:
lipid control
metabolic indices
semaglutide
vitamin D
weight loss
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fnut.2026.1833045/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados